Skip to main content
Premium Trial:

Request an Annual Quote

CareDx Acquires App Developer Transplant Hero

NEW YORK – Transplant diagnostics company CareDx said on Tuesday that it has acquired New York-based Transplant Hero, the developer of a smartphone app that's aimed at supporting the needs of transplant patients.

Financial terms of the deal were not disclosed.

Transplant Hero's app helps transplant patients manage their medications through the use of alarms and interactive logging of medication, CareDx said. The app offers support to various types of organ recipients including kidney, heart, lung, liver, pancreas, and small bowel.

CareDx said that the acquisition of Transplant Hero builds on AlloCare, the company's comprehensive mobile health app for managing patients' day-to-day health before and after transplant. CareDx will add the Transplant Hero app to its digital portfolio, which includes a suite of cloud-based solutions and software for transplant centers and dialysis providers.

"Transplant Hero's easy-to-use interface and transplant focus allows us to expand into different organs," Reg Seeto, CareDx's president and CEO, said in a statement. "We will be able to leverage Transplant Hero's well-established social media presence to augment AlloCare which has been built around patients from kidney transplant centers."

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.